The Royal Marsden NHS Foundation Trust

The Royal Marsden NHS Foundation Trust incorporates The Royal Marsden Hospital in London https://www.royalmarsden.nhs.uk/

View Trust Services

This trust offers the following services:

  • Diagnostic and pre-operative services:
    • On-site PET-CT facilities
    • On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
    • Routine Genetic Testing for Lynch Syndrome
  • Surgical services:
    • On-site hepatobiliary surgical team
    • Robotic surgery
  • Advanced disease services:
    • Dedicated Specialist Advanced Nurse
    • Dedicated Specialist Advanced MDT
    • Dedicated Specialist Advanced Outpatient Clinic
    • Complex vascular reconstruction
    • Distal sacrectomy
    • High sacrectomy
    • Extended lymphadenectomy
  • Support service facilities:
    • Availability of 24 hour palliative care advice
    • 7-day access to face-to-face palliative care services

Data Quality

All Patients: Trust Network National
Number of patients in Audit N/A 1558 35779
Case ascertainment (%) N/A Fair Good
Data completeness of:
– Pre-treatment TNM (%) N/A 81 86
– Performance status (%) N/A 78 89
Patients having major resection: Trust Network National
Number of patients in Audit 41 848 19631
ASA grade 1 (%) 2 22 9
ASA grade 2 (%) 78 52 53
ASA grade 3 (%) 12 21 31
ASA grade 4+ (%) N/A 1 2
ASA grade not recorded (%) 7 4 4
Data completeness of:
7 Audit items for risk-adjustment (%) 93 93 87

Key:

> 80%
50 - 80%
< 50%

Management of all patients

All Patients: Trust Network National
Number of patients in Audit N/A 1558 35779
Seen by Clinical Nurse Specialist (%) N/A 85 88

Management of patients having major resection

Patients having major resection: Trust Network National
Number of patients in Audit 41 848 19614
Distant metastases (%) 15 6 5
Urgent or emergency surgery (%) N/A 10 15
At least 12 lymph nodes excised (%) 90 93 84
Laparoscopic surgery attempted (%) 22 63 72
Risk-adjusted length of stay > 5 days (%) 94 74 55
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit N/A N/A 10747
Adjuvant chemotherapy (%) N/A N/A 62
Patients receiving chemotherapy after major resection for stage III colon cancer: Trust Network National
Number of patients in audit 142 N/A 6608
Severe acute toxicity after adjuvant chemotherapy (%) 15 N/A 22

Rectal cancer patients

Patients having major resection: Trust Network National
Number of patients in Audit 18 N/A 4251
Neoadjuvant therapy (%) 84 N/A 33
Circumferential resection margin: Recorded (%) 100 98 89
Circumferential resection margin: Negative (%) 100 94 83
Rectal volume 25 N/A 4377
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate 100 985 19644
APER/Hartmanns (%) 58 31 37

Compare trust outcomes